SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Quality use of medicines within universal health coverage: challenges and opportunities
15 references·0 citing·47 second hop
Quality use of medicines within universal health coverage: challenges and opportunities (2014)Quality use of medicines within universal…Pharmaceutical policies: effects of financial incentives for prescribers (2015)Pharmaceutical policies: effe…Systems thinking for strengthening health systems in LMICs: need for a paradigm shift (2012)Systems thinking for strength…Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved? (2012)Switching from Originator Bra…SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN (2012)SOCIETAL VIEWS ON NICE, CANCE…THE WORLD MEDICINES SITUATION 2011 (2011)THE WORLD MEDICINES SITUATION…Insured yet vulnerable: out-of-pocket payments and India's poor (2011)Insured yet vulnerable: out-o…Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries (2011)Differences in the availabili…Health systems financing and the path to universal coverage (2010)Health systems financing and …Health insurance systems in five Sub-Saharan African countries: Medicine benefits and data for decision making (2010)Health insurance systems in f…Pharmaceutical policies: effects of cap and co-payment on rational drug use (2008)Pharmaceutical policies: effe…Non-evidence-based policy: How effective is China's new cooperative medical scheme in reducing medical impoverishment? (2008)Non-evidence-based policy: Ho…The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)The availability and affordab…Pharmaceutical policies: effects of financial incentives for prescribers (2007)Pharmaceutical policies: effe…Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2006)Pharmaceutical policies: effe…Problems Paying Out-of-Pocket Medication Costs Among Older Adults With Diabetes (2004)Problems Paying Out-of-Pocket…INTERRUPTED TIME SERIES DESIGNS IN HEALTH TECHNOLOGY ASSESSMENT: LESSONS FROM TWO SYSTEMATIC REVIEWS OF BEHAVIOR CHANGE STRATEGIES (2003)Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration (2008)GRADE guidelines: 3. Rating the quality of evidence (2011)Cost-Containment Policies in Public Pharmaceutical Spending in the EU (2012)Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010 (2012)Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients (2001)QALY maximisation and people's preferences: a methodological review of the literature (2004)Response Rates and Nonresponse Errors in Surveys (2012)Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries (2014)Attributes and weights in health care priority setting: A systematic review of what counts and to what extent (2015)Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature (2017)Mortality by cause for eight regions of the world: Global Burden of Disease Study (1997)Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998 (2003)The Global Burden of Chronic Diseases (2004)How does the New Cooperative Medical Scheme influence health service utilization? A study in two provinces in rural China (2010)The Impact of Health Insurance on Health Outcomes and Spending of the Elderly: Evidence from China's New Cooperative Medical Scheme (2014)World Development Indicators 2005 (2005)Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges (2014)Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2015)Analysis of Health Surveys (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Psychological Reactions to Terrorist Attacks (2002)Beliefs about generic drugs among elderly adults in hospital-based primary care practices (2008)Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008)Hospitalizations and Deaths Among Adults With Cardiovascular Disease Who Underuse Medications Because of Cost (2010)Household catastrophic health expenditure: a multicountry analysis (2003)International labour organization (ILO) (2013)Delivery of affordable and equitable cancer care in India (2014)Financial protection analysis in eight countries in the WHO South-East Asia Region (2018)Quantifying the financial burden of households’ out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994–2014 (2018)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries (2016)Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases (2017)Learning from Evidence in a Complex World (2006)The Fifth Discipline: The Art & Practice of The Learning Organization (2006)Systems thinking for health systems strengthening. (2009)Decentralization of health systems in low and middle income countries: a systematic review (2016)Mathematical modelling for health systems research: a systematic review of system dynamics and agent-based models (2019)Systems Thinking: A Review and Bibliometric Analysis (2020)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)World Population Prospects The 2006 Revision (2007)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Access to medicines from a health system perspective (2012)The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa (2017)Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 (2018)Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries (2018)Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions (2019)
this work references cited by second hop

References

  • 2010Health systems financing and the path to universal coverage1,280 cited
  • 2007The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries487 cited
  • 2011THE WORLD MEDICINES SITUATION 2011427 cited
  • 2012Systems thinking for strengthening health systems in LMICs: need for a paradigm shift331 cited
  • 2004Problems Paying Out-of-Pocket Medication Costs Among Older Adults With Diabetes300 cited
  • 2011Insured yet vulnerable: out-of-pocket payments and India's poor287 cited
  • 2008Non-evidence-based policy: How effective is China's new cooperative medical scheme in reducing medical impoverishment?251 cited
  • 2012SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN208 cited
  • 2006Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies206 cited
  • 2011Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries187 cited
  • 2012Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?178 cited
  • 2008Pharmaceutical policies: effects of cap and co-payment on rational drug use164 cited
  • 2015Pharmaceutical policies: effects of financial incentives for prescribers130 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2010Health insurance systems in five Sub-Saharan African countries: Medicine benefits and data for decision making90 cited
  • 2007Pharmaceutical policies: effects of financial incentives for prescribers60 cited
  • Cited by

    No citing works inside the corpus for this window.